(P770) |
Functional Impact of CXCR4 and CXCR7 Expression in Platelets of Patients with Acute Myocardial Infarction |
|
D. Rath (Tübingen) |
(P771) |
Differential performance and incremental prognostic value of nine biomarkers in patients admitted with non-ST-elevation acute coronary syndrome |
|
C. Widera, M. J. Pencina, M. Bobadilla, I. Reimann, A. Guba-Quint, I. Marquardt, K. Bethmann, M. Korf-Klingebiel, T. Kempf, R. Lichtinghagen, H. A. Katus, E. Giannitsis, K. C. Wollert (Hannover, Heidelberg; Boston, US; Basel, CH) |
(P772) |
Comparison of a Super-Sensitivity with a High-Sensitivity Cardiac Troponin I Assay for the Diagnosis of Acute Myocardial Infarction |
|
N. Schofer, F. Brunner, M. Schlüter, F. Ojeda-Echevarria, T. Zeller, S. Baldus, C. Bickel, K. J. Lackner, T. Münzel, S. Tzikas, T. Keller, S. Blankenberg, B. Goldmann (Hamburg, Köln, Koblenz, Mainz, Frankfurt am Main) |
(P773) |
Copeptin as a Part of the Dual Biomarker Strategy for Early Diagnosis of non-ST Segment Elevation Myocardial Infarction – WILCOP-Study |
|
M. Tajsic, R. Jarai, M. Schwarz, J. Kitzbrecht, J. Koch, K. Huber, J. Wojta (Wien, AT) |
(P774) |
Neuropeptide Y levels are associated with anxiety scores in coronary heart disease patients |
|
C. Waller, U. Hoppmann, S. Krause, J. Distler, H. Gündel, S. von Hörsten (Ulm, Erlangen) |
(P775) |
Association of plasma amyloid-β (1-40) levels with subclinical atherosclerosis, incident coronary artery disease and cardiovascular mortality |
|
K. Stamatelopoulos, D. Sibbing, D. Stakos, S.-L. Braun, A. Gatsiou, K. Sopova, A. Kastrati, K. Stellos (Athens, Alexandroupolis, GR; München, Frankfurt am Main) |
(P776) |
Cystein rich protein 61 serum concentration in chronic heart failure-a new biomarker in heart failure? |
|
M. Fritzenwanger, C. Jung, M. Franz, H.-R. Figulla (Jena) |
(P777) |
Prognostic Implications of Increased High-Sensitivity Troponin T in Acute Coronary Syndrome and in the Absence of Acute Coronary Syndrome among Patients Presenting to an Emergency Department |
|
M. Müller, M. Biener, M. Vafaie, S. Doerr, H. White, H. A. Katus, E. Giannitsis (Heidelberg; Auckland, NZ) |
(P778) |
HsTroponin I nach akuter kardialer Dekompensation - Prognostischer Stellenwert und Zusammenhang mit der Herzinsuffizienzätiologie |
|
J. Wallenborn, S. Stauffenberg, S. Störk, D. Berliner, P. U. Heuschmann, G. Ertl, C. E. Angermann für das KNHI (Würzburg, Hannover) |
(P779) |
Evolving Biomarkers Improve Prediction of Long-Term Mortality in Patients with Stable CAD – The BIO-VILCAD Score |
|
G. Goliasch, M. Kleber, T. Grammer, S. Pilz, A. Tomaschitz, G. Silbernagel, G. Maurer, W. März, A. Niessner (Wien, Graz, AT; Mannheim, Tübingen) |
(P780) |
Association between RANKL and neuroendocrine activation in patients with heart failure |
|
G. Loncar, B. Bozic, E. Tahirovic, V. Cvorovic, N. Prodanovic, Z. Radojicic, V. Popovic, F. Krackhardt, H.-D. Düngen (Belgrad, CS; Berlin) |
(P781) |
Panel of innovative cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure |
|
C. G. Jungbauer, J. Riedlinger, S. Stadler, M. Büsing, D. Block, W. König, G. Riegger, A. Luchner (Regensburg, Penzberg, Ulm) |
(P782) |
Circulating Concentrations of Fibroblast Activation Protein α in Healthy Individuals and Patients with Acute Coronary Syndrome |
|
J. Tillmanns, C. Widera, Y. Habbaba, P. Galuppo, T. Kempf, K. C. Wollert, J. Bauersachs (Hannover) |
(P783) |
Einfluss einer Niereninsuffizienz auf die Korrelation von NTproBNP mit dem Schweregrad der Herzinsuffizienz |
|
A. Rieth, J. Pons-Kühnemann, O. Teichert, V. Mitrovic, C. W. Hamm (Bad Nauheim, Gießen) |
(P784) |
Der Matrix Turn-Over-Score (MTS): Ein neuer Prädiktor des transplantationsfreien Überlebens bei Patienten mit einer Dilatativen Kardiomyopathie |
|
F. Küthe, P. Schlattmann, K. Grün, F. Reinbothe, C. Jung, C. Porrmann, G. Mall, K. Galler, D. Neri, A. Berndt, H.-R. Figulla, M. Franz (Jena, Darmstadt; Zürich, CH) |